Medicure Inc. (MPH.V)
CAD 0.89
(0.0%)
CAD 0.89
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 13.98 Million CAD | -15.68% |
| 2022 | 16.07 Million CAD | 26.46% |
| 2021 | 12.71 Million CAD | 147.8% |
| 2020 | 5.13 Million CAD | -60.24% |
| 2019 | 12.9 Million CAD | -48.31% |
| 2018 | 24.95 Million CAD | 5.45% |
| 2017 | 23.66 Million CAD | -15.5% |
| 2016 | 28 Million CAD | 41.29% |
| 2015 | 19.82 Million CAD | 147.94% |
| 2014 | 7.99 Million CAD | 91.15% |
| 2013 | 4.18 Million CAD | 115.96% |
| 2012 | 1.93 Million CAD | -48.04% |
| 2011 | 3.72 Million CAD | 26.15% |
| 2010 | 2.95 Million CAD | 7.63% |
| 2009 | 2.74 Million CAD | -37.82% |
| 2008 | 4.41 Million CAD | 168.99% |
| 2007 | 1.64 Million CAD | -70.46% |
| 2006 | 5.55 Million CAD | 1753.93% |
| 2005 | 299.73 Thousand CAD | -34.73% |
| 2004 | 459.19 Thousand CAD | 3.08% |
| 2003 | 445.46 Thousand CAD | 84.62% |
| 2002 | 241.28 Thousand CAD | 31.19% |
| 2001 | 183.91 Thousand CAD | 35.36% |
| 2000 | 135.86 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.89 Million CAD | 73.2% |
| 2024 Q2 | 2.95 Million CAD | -24.25% |
| 2023 Q2 | 4.07 Million CAD | 7.24% |
| 2023 FY | 13.55 Million CAD | -15.68% |
| 2023 Q1 | 3.79 Million CAD | -12.92% |
| 2023 Q3 | 3.64 Million CAD | -10.59% |
| 2023 Q4 | 2.25 Million CAD | -38.19% |
| 2022 Q4 | 4.35 Million CAD | 11.88% |
| 2022 Q3 | 3.89 Million CAD | 2.66% |
| 2022 Q2 | 3.79 Million CAD | -5.71% |
| 2022 Q1 | 4.02 Million CAD | 6.43% |
| 2022 FY | 16.07 Million CAD | 26.46% |
| 2021 Q2 | 3.03 Million CAD | 1.0% |
| 2021 Q4 | 3.78 Million CAD | 31.23% |
| 2021 Q1 | 3 Million CAD | 990.22% |
| 2021 FY | 12.71 Million CAD | 147.8% |
| 2021 Q3 | 2.88 Million CAD | -5.17% |
| 2020 Q3 | 2.18 Million CAD | 82.17% |
| 2020 FY | 5.13 Million CAD | -60.24% |
| 2020 Q1 | 1.46 Million CAD | 1568.18% |
| 2020 Q2 | 1.2 Million CAD | -18.26% |
| 2020 Q4 | 276 Thousand CAD | -87.37% |
| 2019 Q1 | 3.84 Million CAD | -42.72% |
| 2019 FY | 12.9 Million CAD | -48.31% |
| 2019 Q2 | 4.94 Million CAD | 28.79% |
| 2019 Q3 | 4.02 Million CAD | -18.69% |
| 2019 Q4 | 88 Thousand CAD | -97.81% |
| 2018 Q3 | 6.37 Million CAD | -3.38% |
| 2018 FY | 24.95 Million CAD | 5.45% |
| 2018 Q1 | 5.27 Million CAD | 41.09% |
| 2018 Q4 | 6.7 Million CAD | 5.2% |
| 2018 Q2 | 6.59 Million CAD | 25.09% |
| 2017 Q3 | 6.19 Million CAD | -58.08% |
| 2017 FY | 23.66 Million CAD | -15.5% |
| 2017 Q1 | 6.05 Million CAD | -30.89% |
| 2017 Q4 | 3.73 Million CAD | -39.63% |
| 2017 Q2 | 14.77 Million CAD | 143.91% |
| 2016 Q3 | 7.21 Million CAD | 5.47% |
| 2016 Q2 | 6.83 Million CAD | 31.64% |
| 2016 FY | 28 Million CAD | 41.29% |
| 2016 Q1 | 5.19 Million CAD | -40.41% |
| 2016 Q4 | 8.76 Million CAD | 21.55% |
| 2015 Q2 | 3.28 Million CAD | 11.62% |
| 2015 Q4 | 8.71 Million CAD | 78.83% |
| 2015 Q1 | 2.94 Million CAD | 0.0% |
| 2015 FY | 19.82 Million CAD | 147.94% |
| 2015 Q3 | 4.87 Million CAD | 48.25% |
| 2014 Q3 | 1.84 Million CAD | 20.19% |
| 2014 Q2 | 1.53 Million CAD | 10.76% |
| 2014 Q1 | 1.38 Million CAD | 107.69% |
| 2014 FY | 7.99 Million CAD | 91.15% |
| 2013 Q2 | 613.99 Thousand CAD | 160.88% |
| 2013 FY | 4.18 Million CAD | 115.96% |
| 2013 Q4 | 668.96 Thousand CAD | 14.27% |
| 2013 Q3 | 585.44 Thousand CAD | -4.65% |
| 2013 Q1 | 235.35 Thousand CAD | -58.22% |
| 2012 Q1 | 412.92 Thousand CAD | -79.33% |
| 2012 Q2 | 115.83 Thousand CAD | -71.95% |
| 2012 Q3 | 524.18 Thousand CAD | 352.54% |
| 2012 Q4 | 563.27 Thousand CAD | 7.46% |
| 2012 FY | 1.93 Million CAD | -48.04% |
| 2011 Q2 | 245.72 Thousand CAD | -78.66% |
| 2011 Q3 | 1.2 Million CAD | 388.74% |
| 2011 Q4 | 1.99 Million CAD | 66.35% |
| 2011 Q1 | 1.15 Million CAD | 50.31% |
| 2011 FY | 3.72 Million CAD | 26.15% |
| 2010 Q3 | 791.61 Thousand CAD | 52.51% |
| 2010 Q4 | 766 Thousand CAD | -3.24% |
| 2010 FY | 2.95 Million CAD | 7.63% |
| 2010 Q1 | 417.17 Thousand CAD | -54.75% |
| 2010 Q2 | 519.06 Thousand CAD | 24.42% |
| 2009 Q2 | 543.14 Thousand CAD | -61.11% |
| 2009 Q3 | 887.17 Thousand CAD | 63.34% |
| 2009 Q4 | 921.97 Thousand CAD | 3.92% |
| 2009 FY | 2.74 Million CAD | -37.82% |
| 2009 Q1 | 1.39 Million CAD | 1.73% |
| 2008 Q4 | 1.37 Million CAD | 24.45% |
| 2008 Q3 | 1.1 Million CAD | 332.33% |
| 2008 FY | 4.41 Million CAD | 168.99% |
| 2008 Q1 | 668.86 Thousand CAD | 142.76% |
| 2008 Q2 | 255.13 Thousand CAD | -61.86% |
| 2007 Q4 | 275.52 Thousand CAD | -37.66% |
| 2007 Q2 | 1.57 Million CAD | -32.81% |
| 2007 Q1 | 2.34 Million CAD | 71.91% |
| 2007 FY | 1.64 Million CAD | -70.46% |
| 2007 Q3 | 441.98 Thousand CAD | -71.96% |
| 2006 Q1 | - CAD | -100.0% |
| 2006 Q4 | 1.36 Million CAD | 404.45% |
| 2006 Q2 | - CAD | 0.0% |
| 2006 Q3 | 270.49 Thousand CAD | 0.0% |
| 2006 FY | 5.55 Million CAD | 1753.93% |
| 2005 Q3 | 37.17 Thousand CAD | -67.45% |
| 2005 Q4 | 34.68 Thousand CAD | -6.71% |
| 2005 FY | 299.73 Thousand CAD | -34.73% |
| 2005 Q1 | 214.3 Thousand CAD | 121.01% |
| 2005 Q2 | 114.19 Thousand CAD | -46.72% |
| 2004 Q4 | 96.97 Thousand CAD | -8.97% |
| 2004 FY | 459.19 Thousand CAD | 3.08% |
| 2004 Q2 | 128.08 Thousand CAD | -21.21% |
| 2004 Q3 | 106.52 Thousand CAD | -16.83% |
| 2004 Q1 | 162.55 Thousand CAD | 101.61% |
| 2003 FY | 445.46 Thousand CAD | 84.62% |
| 2003 Q1 | 68.73 Thousand CAD | 0.0% |
| 2003 Q2 | 47.83 Thousand CAD | -30.41% |
| 2003 Q4 | 80.62 Thousand CAD | 8.65% |
| 2003 Q3 | 74.2 Thousand CAD | 55.12% |
| 2002 Q3 | 67.45 Thousand CAD | 0.0% |
| 2002 FY | 241.28 Thousand CAD | 31.19% |
| 2002 Q4 | - CAD | -100.0% |
| 2001 FY | 183.91 Thousand CAD | 35.36% |
| 2000 FY | 135.86 Thousand CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | 5499.00 CAD | -254291.708% |
| CanadaBis Capital Inc. | 11.78 Million CAD | -18.715% |
| Decibel Cannabis Company Inc. | 41.85 Million CAD | 66.581% |
| Delivra Health Brands Inc. | 6.39 Million CAD | -118.612% |
| Entourage Health Corp. | 3.7 Million CAD | -277.296% |
| Lifeist Wellness Inc. | 5.34 Million CAD | -161.756% |
| Cannara Biotech Inc. | 27.23 Million CAD | 48.628% |
| PharmaCielo Ltd. | -1.36 Million CAD | 1121.962% |
| Rubicon Organics Inc. | 13.14 Million CAD | -6.455% |
| BioSyent Inc. | 25.14 Million CAD | 44.361% |
| Voyageur Pharmaceuticals Ltd. | -2185.00 CAD | 640328.833% |